Pulmotect, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2007)

Organization Overview

First Clinical Trial
2014
NCT02124278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pulmotect, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

pul-042 (6 trials)

Drugs in Phase 1 Trials (2)

albuterol (proventil) (1 trial)

cromoglicic acid (Intal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease Progression (Phase 2)

Hematologic Diseases (Phase 1)

Infections (Phase 2)

Respiratory Aspiration (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 3